Authors:
CAPRON D
BENSOUSAN T
DARCHIS JP
BARBARE JC
BUTEL J
BENTAL A
CADRANEL JF
GOLL A
LEVY P
INK O
AUTRET P
BOURAYA D
THIEBAUT JM
MOUCHERON JJ
BERNARD M
LALLEMENT PY
DELOBEL P
Citation: D. Capron et al., RISK-FACTORS FOR HEPATITIS-C VIRUS-INFECTION IN PATIENTS ADMITTED TO EMERGENCY UNITS OF PICARDY-HOSPITALS - THE VALVE OF SCREENING BASED ONRECOMMENDATIONS FROM THE PUBLIC-HEALTH BOARD, Gastroenterologie clinique et biologique, 22(6-7), 1998, pp. 646-647
Authors:
BARBARE JC
DARNIGE L
ARVIEUX J
LAUMONIER O
CORBASSON C
CAPRON D
CADRANEL JF
LATRIVE JP
PIETTE JC
CAPRON JP
Citation: Jc. Barbare et al., PREVALENCE AND ISOTYPE OF ANTIPHOSPHOLIPID AND ANTI-BETA-2-GLYCOPROTEIN-I ANTIBODIES IN ALCOHOLIC DISEASE, Hepatology, 28(4), 1998, pp. 139-139
Authors:
CADRANEL JF
CAPRON D
LAMBREY G
NALET B
ANCIAUX ML
RICHARD C
BIGUE JP
BARION JN
BORIES C
BARBARE JC
HALIMI C
RIBIERE O
EUGENE C
PAUWELS A
DIMARTINO V
MORILON C
DONATO L
PARIENTE A
DEVERGIE B
Citation: Jf. Cadranel et al., PREVALENCE AND RISK-FACTORS OF HEPATITIS-C VIRUS (HCV) INFECTION IN HOSPITALIZED DIABETIC (DB) PATIENTS (PTS) - RESULTS OF A PROSPECTIVE MULTICENTER STUDY IN 1561 CONSECUTIVE PATIENTS, Hepatology, 28(4), 1998, pp. 1225-1225
Authors:
DIMARTINO CV
GAYNO S
CADRANEL JF
GAUDIN B
BOUR B
CAUSSE X
GARGOT D
BARBARE JC
WESENFELDER L
PARIENTE A
SERRAZIN V
HARZIC M
EUGENE C
Citation: Cv. Dimartino et al., PRETHERAPEUTIC CONDITIONMENT ENHANCES THE RESPONSE TO INTERFERON THERAPY OF CHRONIC HEPATITIS, Hepatology, 28(4), 1998, pp. 2154-2154
Authors:
ROUDOTTHORAVAL F
BASTIE A
PAWLOTSKY JM
DHUMEAUX D
AUDIGIER JC
BARBARE JC
BAUDET JG
BEAUGRAND M
BERTHELOT P
BRECHOT C
POL S
CATTAN D
BETTAN L
CHAPUT JC
COUZIGOU P
DAO MT
DENIS J
DOFFOEL M
DRUCKER J
ERLINGER S
MARCELLIN P
ETIENNE JP
BUFFET C
LAURENTPUIG P
FILOCHE B
GAUCHER P
GAUTHIER A
DELREZ R
INK O
METMAN E
BACQ Y
MICHEL H
LARREY D
MIGUET JP
BRESSONHADNI S
MORICHAUBEAUCHANT M
OPOLON P
POYNARD T
PASCAL JP
PAYEN JL
POUPON R
SERFATY L
SONDAG D
TERRIS G
TREPO C
AHMED SNS
WAGNER JC
ZARSKI JP
MAYNARD M
Citation: F. Roudotthoraval et al., EPIDEMIOLOGIC FACTORS AFFECTING THE SEVERITY OF HEPATITIS-C VIRUS-RELATED LIVER-DISEASE - A FRENCH SURVEY OF 6,664 PATIENTS, Hepatology, 26(2), 1997, pp. 485-490
Citation: Jc. Barbare, TAMOXIFEN AND HEPATOCELLULAR-CARCINOMA - AFTER THE ENTHUSIASM, THE VERDICT, Gastroenterologie clinique et biologique, 20(6-7), 1996, pp. 609-610
Authors:
BONNARD P
VITTE RL
BARBARE JC
DENIS J
TOSSOU H
DELLION MP
EUGENE C
DEVERGIE B
HARRY G
CADRANEL L
Citation: P. Bonnard et al., THE MEANING OF THE BLEEDING-TIME (BT), WHEN CHOOSING A LIVER-BIOPSY (LB) ROUTE - RESULTS OF A MULTICENTRIC STUDY REFERRING TO 219 CONSECUTIVE EXAMS, Gastroenterology, 110(4), 1996, pp. 1154-1154
Authors:
CADRANEL JF
DENIS J
BARBARE JC
MEDINI A
EUGENE C
POQUET E
LATRIVE JP
PAUWELS A
DEVERGIE B
Citation: Jf. Cadranel et al., PREVALENCE AND RISK-FACTORS OF URINARY-TRACT INFECTION IN CIRRHOTICS - A PROSPECTIVE CASE-CONTROL MULTICENTRIC STUDY, Gastroenterology, 108(4), 1995, pp. 1042-1042
Authors:
CHAZOUILLERES O
POUPON R
GATINEAUSAILLANT G
ROULOT D
BARBARE JC
LABADIE H
MAL F
JOLY JP
BOUTIN B
Citation: O. Chazouilleres et al., BENEFICIAL EFFECT OF LOW-MOLECULAR-WEIGHT HEPARIN (FRAXIPARINE(R)) ONSHORT-TERM MORTALITY IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR-CARCINOMA (HCC) - A RANDOMIZED STUDY, Gastroenterology, 106(4), 1994, pp. 10000874-10000874